Psoriasis drugs may also protect the heart, study suggests
NCT ID NCT07169682
First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 32 times
Summary
This study looked at whether newer psoriasis medications (IL17 and IL23 inhibitors) can also help reduce early signs of heart disease. Researchers measured artery stiffness in 66 patients with moderate-to-severe psoriasis before and after one year of treatment. The goal was to see if these drugs improve blood vessel health compared to standard treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Andreas Sygros Hospital
Athens, 17124, Greece
Conditions
Explore the condition pages connected to this study.